Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.

van Amerongen R, Gazendam RP, van Bergen JEAM.

BMC Fam Pract. 2019 Jan 15;20(1):12. doi: 10.1186/s12875-018-0900-9.

2.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

3.

[A young man with a scrotal rash; bedbugs or something else?]

van Bergen JEAM, Robberse EJ, van Dam AP.

Ned Tijdschr Geneeskd. 2018 May 16;162. pii: D2766. Dutch.

PMID:
30040323
4.

[Chlamydia: a pill for the partner? Results of the PICC-UP project on patient-initiated partner therapy].

Götz HM, van Bergen JEAM, Philips-Santman C, van Benthem BHB.

Ned Tijdschr Geneeskd. 2018 May 18;162. pii: D2703. Dutch.

PMID:
30040313
5.

[Epidemiology of sexually transmitted infections; how should the Dutch data be interpreted?]

van Bergen JEAM, de Vries HJC, van Benthem BHB.

Ned Tijdschr Geneeskd. 2018 May 18;162. pii: D2736. Dutch.

PMID:
30040295
6.

National prevalence estimates of chlamydia and gonorrhoea in the Netherlands.

Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB.

Sex Transm Infect. 2019 Feb;95(1):53-59. doi: 10.1136/sextrans-2017-053478. Epub 2018 Jun 20.

PMID:
29925670
7.

Development and evaluation of a blended educational programme for general practitioners' trainers to stimulate proactive HIV testing.

Joore IK, van Bergen JEAM, Ter Riet G, van der Maat A, van Dijk N.

BMC Fam Pract. 2018 Mar 7;19(1):36. doi: 10.1186/s12875-018-0723-8.

8.

Partner notification and partner treatment for chlamydia: attitude and practice of general practitioners in the Netherlands; a landscape analysis.

van den Broek IVF, Donker GA, Hek K, van Bergen JEAM, van Benthem BHB, Götz HM.

BMC Fam Pract. 2017 Dec 20;18(1):103. doi: 10.1186/s12875-017-0676-3.

9.

Improving early HIV diagnosis, treatment and care in Europe with healthcare provider specific HIV indicator condition list and audits.

Twisk DE, Joore IK, van Bergen JEAM.

Sex Transm Infect. 2017 Dec;93(8):582. doi: 10.1136/sextrans-2016-053091. No abstract available.

PMID:
29175994
10.

HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam.

Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative.

BMC Infect Dis. 2017 Aug 1;17(1):529. doi: 10.1186/s12879-017-2617-0.

11.

[Mapping HIV prevalence in the Netherlands with geographic information systems].

Op de Coul ELM, Joore IK, van Sighem A, Bom BCJ, Hillebregt M, Prins JM, Geerlings SE, van Bergen JEAM.

Ned Tijdschr Geneeskd. 2017;161:D965. Dutch.

PMID:
28677511
12.

Effectiveness of an individual, online e-learning program about sexually transmitted infections: a prospective cohort study.

Bos-Bonnie LHA, van Bergen JEAM, Te Pas E, Kijser MA, van Dijk N.

BMC Fam Pract. 2017 Apr 24;18(1):57. doi: 10.1186/s12875-017-0625-1.

13.

A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study.

den Heijer CDJ, Hoebe CJPA, van Liere GAFS, van Bergen JEAM, Cals JWL, Stals FS, Dukers-Muijrers NHTM.

BMC Infect Dis. 2017 Apr 20;17(1):290. doi: 10.1186/s12879-017-2402-0.

14.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

15.

The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment.

Joore IK, Geerlings SE, Brinkman K, van Bergen JE, Prins JM.

BMC Infect Dis. 2017 Feb 28;17(1):178. doi: 10.1186/s12879-017-2279-y.

16.

The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.

Joore IK, Twisk DE, Vanrolleghem AM, de Ridder M, Geerlings SE, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2016 Nov 17;17(1):161.

17.

Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.

Xiridou M, Lugnér A, de Vries HJ, van Bergen JE, Götz HM, van Benthem BH, Wallinga J, van der Sande MA.

Sex Transm Dis. 2016 Sep;43(9):542-8. doi: 10.1097/OLQ.0000000000000480.

PMID:
27513379
18.

Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care.

Dukers-Muijrers NH, Wolffs PF, Eppings L, Götz HM, Bruisten SM, Schim van der Loeff MF, Janssen K, Lucchesi M, Heijman T, van Benthem BH, van Bergen JE, Morre SA, Herbergs J, Kok G, Steenbakkers M, Hogewoning AA, de Vries HJ, Hoebe CJ.

BMC Infect Dis. 2016 Aug 8;16:381. doi: 10.1186/s12879-016-1721-x.

19.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, van Benthem BH.

BMC Infect Dis. 2016 Aug 2;16:364. doi: 10.1186/s12879-016-1707-8.

20.

General practitioners' barriers and facilitators towards new provider-initiated HIV testing strategies: a qualitative study.

Joore IK, van Roosmalen SL, van Bergen JE, van Dijk N.

Int J STD AIDS. 2017 Apr;28(5):459-466. doi: 10.1177/0956462416652274. Epub 2016 Jul 10.

21.

Missed opportunities to offer HIV tests to high-risk groups during general practitioners' STI-related consultations: an observational study.

Joore IK, Reukers DF, Donker GA, van Sighem AI, Op de Coul EL, Prins JM, Geerlings SE, Barth RE, van Bergen JE, van den Broek IV.

BMJ Open. 2016 Jan 21;6(1):e009194. doi: 10.1136/bmjopen-2015-009194.

22.

Predictors of Chlamydia Trachomatis testing: perceived norms, susceptibility, changes in partner status, and underestimation of own risk.

Ten Hoor GA, Ruiter RAC, van Bergen JEAM, Hoebe CJPA, Dukers-Muijrers NHTM, Kok G.

BMC Public Health. 2016 Jan 20;16:55. doi: 10.1186/s12889-016-2689-6.

23.

Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.

van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, Götz HM, Uusküla A, Woodhall SC, Redmond SM, Amato-Gauci AJ, Low N, van Bergen JE.

Eur J Public Health. 2016 Jun;26(3):382-8. doi: 10.1093/eurpub/ckv196. Epub 2015 Oct 24.

24.

[Earlier case finding and immediate treatment of HIV: Time2Act].

van Bergen JE.

Ned Tijdschr Geneeskd. 2015;159:A9487. Dutch.

PMID:
26271176
25.

Who tests whom? A comprehensive overview of Chlamydia trachomatis test practices in a Dutch region among different STI care providers for urogenital, anorectal and oropharyngeal sites in young people: a cross-sectional study.

den Heijer CD, van Liere GA, Hoebe CJ, van Bergen JE, Cals JW, Stals FS, Dukers-Muijrers NH.

Sex Transm Infect. 2016 May;92(3):211-7. doi: 10.1136/sextrans-2015-052065. Epub 2015 Aug 11.

PMID:
26265066
26.

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.

Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE; Medical Microbiological Laboratories and the CSI group.

Cancer Med. 2015 Oct;4(10):1589-98. doi: 10.1002/cam4.496. Epub 2015 Jul 21.

27.

HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case-control study in primary care.

Joore IK, Arts DL, Kruijer MJ, Moll van Charante EP, Geerlings SE, Prins JM, van Bergen JE.

Sex Transm Infect. 2015 Nov;91(7):467-72. doi: 10.1136/sextrans-2015-052073. Epub 2015 Jun 30.

PMID:
26126531
28.

Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices.

Woestenberg PJ, van Oeffelen AA, Stirbu-Wagner I, van Benthem BH, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2015 Jun 18;16:70. doi: 10.1186/s12875-015-0281-2.

29.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
30.

The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study.

van Liere GA, Dukers-Muijrers NH, van Bergen JE, Götz HM, Stals F, Hoebe CJ.

BMC Infect Dis. 2014 Nov 18;14:612. doi: 10.1186/s12879-014-0612-2.

31.

[Patients with a sexually transmitted infection. The abc of the consult is not as simple as it seems].

van Bergen JE.

Ned Tijdschr Geneeskd. 2014;158:A7247. Review. Dutch.

PMID:
24846113
32.

Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

van den Broek IV, Land JA, van Bergen JE, Morré SA, van der Sande MA.

Obstet Gynecol Int. 2014;2014:601932. doi: 10.1155/2014/601932. Epub 2014 Mar 13.

33.

Population- and type-specific clustering of multiple HPV types across diverse risk populations in the Netherlands.

Mollers M, Vriend HJ, van der Sande MA, van Bergen JE, King AJ, Lenselink CH, Bekkers RL, Meijer CJ, de Melker HE, Bogaards JA.

Am J Epidemiol. 2014 May 15;179(10):1236-46. doi: 10.1093/aje/kwu038. Epub 2014 Apr 8.

PMID:
24714726
34.

[Summary of the NHG guideline 'The STD consultation'].

Verlee EL, van Bergen JE, Dekker JH, Boeke AJ, Burgers JS, Bouma M.

Ned Tijdschr Geneeskd. 2014;158:A7277. Review. Dutch.

PMID:
24690519
35.

Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.

van Aar F, de Moraes M, Morré SA, van Bergen JE, van der Klis FR, Land JA, van der Sande MA, van den Broek IV.

Sex Transm Infect. 2014 Aug;90(5):434-40. doi: 10.1136/sextrans-2013-051074. Epub 2014 Feb 28.

PMID:
24583966
36.

The influence of two different invitation letters on Chlamydia testing participation: randomized controlled trial.

Ten Hoor G, Hoebe CJ, van Bergen JE, Brouwers EE, Ruiter RA, Kok G.

J Med Internet Res. 2014 Jan 30;16(1):e24. doi: 10.2196/jmir.2907.

37.

Consultations for sexually transmitted infections in the general practice in the Netherlands: an opportunity to improve STI/HIV testing.

Trienekens SC, van den Broek IV, Donker GA, van Bergen JE, van der Sande MA.

BMJ Open. 2013 Dec 30;3(12):e003687. doi: 10.1136/bmjopen-2013-003687.

38.

Non-participation in chlamydia screening in The Netherlands: determinants associated with young people's intention to participate in chlamydia screening.

ten Hoor GA, Ruiter RA, van Bergen JE, Hoebe CJ, Houben K, Kok G.

BMC Public Health. 2013 Nov 23;13:1091. doi: 10.1186/1471-2458-13-1091.

39.

Using intervention mapping for the development of a targeted secure web-based outreach strategy named SafeFriend, for Chlamydia trachomatis testing in young people at risk.

Theunissen KA, Hoebe CJ, Crutzen R, Kara-Zaïtri C, de Vries NK, van Bergen JE, van der Sande MA, Dukers-Muijrers NH.

BMC Public Health. 2013 Oct 22;13:996. doi: 10.1186/1471-2458-13-996.

40.

Low positivity rate after systematic screening for Trichomonas vaginalis in three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study.

Geelen TH, Hoebe CJ, Dirks A, Dukers-Muijrers NH, van Bergen JE, Wolffs PF.

Sex Transm Infect. 2013 Sep;89(6):532-4. doi: 10.1136/sextrans-2012-051010. Epub 2013 Jul 2.

PMID:
23821769
41.

[Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].

Koedijk FD, van den Broek I, Stirbu-Wagner I, van Bergen JE.

Ned Tijdschr Geneeskd. 2013;157(24):A5642. Review. Dutch.

PMID:
23759175
42.

[Earlier implementation of HIV testing].

Brinkman K, van Bergen JE.

Ned Tijdschr Geneeskd. 2013;157(15):A6120. Dutch.

PMID:
23575294
43.

Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, Götz HM, Hoebe CJ, de Wit GA, van der Sande MA, Kretzschmar ME.

PLoS One. 2013;8(3):e58674. doi: 10.1371/journal.pone.0058674. Epub 2013 Mar 20.

44.

The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006-2010.

Koedijk FD, van Bergen JE, Dukers-Muijrers NH, van Leeuwen AP, Hoebe CJ, van der Sande MA; Dutch STI centres.

Int J STD AIDS. 2012 Sep;23(9):626-31. doi: 10.1258/ijsa.2012.011378.

PMID:
23033514
45.

Normalizing HIV testing in primary care. Commentary on: Late HIV diagnoses in Europe: a call for increased testing and awareness among general practitioners.

van Bergen JE.

Eur J Gen Pract. 2012 Sep;18(3):133-5. doi: 10.3109/13814788.2012.704361. No abstract available.

PMID:
22954191
46.

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Koekenbier RH, Kretzschmar M, Over EA, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MA, de Wit GA, Low N, Op de Coul EL.

BMJ. 2012 Jul 5;345:e4316. doi: 10.1136/bmj.e4316.

47.

Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Dokkum NF, Koekenbier RH, van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Pars LL, van Ravesteijn SM, Op de Coul EL.

BMC Public Health. 2012 Mar 9;12:176. doi: 10.1186/1471-2458-12-176.

48.

Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Op de Coul EL, Götz HM, van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van der Sande MA, van den Broek IV.

Sex Transm Dis. 2012 Feb;39(2):97-103. doi: 10.1097/OLQ.0b013e3182383097.

PMID:
22249297
49.

Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective.

van den Broek IV, Brouwers EE, Götz HM, van Bergen JE, Op de Coul EL, Fennema JS, Koekenbier RH, Pars LL, van Ravesteijn SM, Hoebe CJ.

Sex Transm Infect. 2012 Apr;88(3):205-11. doi: 10.1136/sextrans-2011-050219. Epub 2012 Jan 3.

PMID:
22215696
50.

Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse.

Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van den Broek IV.

Sex Transm Dis. 2011 Jun;38(6):467-74. doi: 10.1097/OLQ.0b013e318204546e.

PMID:
21217416

Supplemental Content

Loading ...
Support Center